GREENWICH LIFESCIENC

GLSI
Delayed Quote. Delayed  - 01/19 04:00:00 pm
37.27USD -0.48%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019
Net sales --
EBITDA1 -1,69-3,42
Operating profit (EBIT)1 -1,69-3,43
Operating Margin --
Pre-Tax Profit (EBT)1 -1,69-3,43
Net income1 -1,69-3,43
Net margin --
EPS2 -8,32-1,52
Dividend per Share --
Last update 05/29/202005/29/2020
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2018 2019
Net Debt1 0,340,63
Net Cash position1 --
Leverage (Debt / EBITDA) -0,20x-0,18x
Free Cash Flow --1,51
ROE (Net Profit / Equities) -59,7%
Shareholders' equity1 --5,74
ROA (Net Profit / Asset) --3 167%
Assets1 -0,11
Book Value Per Share2 -49,9-0,16
Cash Flow per Share2 0,420,00
Capex --
Capex / Sales --
Last update 05/29/202005/29/2020
1 USD in Million
2 USD
Balance Sheet Analysis
EPS & Dividend